MarketPulse

ADC (antibody drug conjugate)

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Boehringer Ingelheim, Zai Lab Partner on DLL3 Combo Therapy for Lung Cancer

Boehringer Ingelheim and Zai Lab collaborate on Phase Ib/II study combining T-cell engager obrixtamig with ADC zocilurtatug for small cell lung cancer treatment.
ZLABADC (antibody drug conjugate)immuno-oncology
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Day One Biopharmaceuticals Posts 172% Revenue Growth on OJEMDA Sales Strength

Day One Biopharmaceuticals reports 172% revenue growth to $155.4M, driven by OJEMDA sales strength. Company acquires Mersana Therapeutics to expand pipeline.
DAWNclinical trialsrevenue growth